Slowing down ALS with speech: Study uses IBM AI to create digital biomarkers
The study EverythingALS is working with clinical research stakeholders from IBM Research, Massachusetts Institute of Technology, and Harvard University in a longitudinal study focused on early disease detection based on patterns scored in audiovisual sessions. The study includes more than 800 participants diagnosed with amyotrophic lateral sclerosis (ALS), caregivers, those suspected of developing ALS due …
Slowing down ALS with speech: Study uses IBM AI to create digital biomarkers Read More »
